Summer Sale Get Elite for just $199.50

00

Days

00

Hours

00

Mins

00

Sec

Claim Now

ReShape Lifesciences Inc

Contributing Author

Recent Articles by ReShape Lifesciences Inc

Jul-24	ReShape Lifesciences Announces Partial Adjournment of Special Meeting of Stockholders GlobeNewswire
Jul-22	ReShape Lifesciences to Host Inaugural Lap-Band Surgeon Summit GlobeNewswire
Jul-21	ReShape Lifesciences to Host Special Meeting of Stockholders on July 24, 2025 GlobeNewswire
Jul-01	ReShape Lifesciences Granted U.S. Patent Related to an Intragastric Balloon System GlobeNewswire
Jun-27	ReShape Lifesciences Regains Compliance with Nasdaq Minimum Stockholders Equity Requirement GlobeNewswire
Jun-26	ReShape Lifesciences Announces Strategic Cost Reductions and Provides Update on the Merger Agreement with Vyome Therapeutics and Asset Purchase Agreement with Biorad Medisys GlobeNewswire
Jun-25	ReShape Lifesciences Granted Key International Patent in Australia for Its Proprietary Diabetes Neuromodulation Technology GlobeNewswire
Jun-12	ReShape Lifesciences Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets GlobeNewswire
Jun-09	ReShape Lifesciences Announces Pricing of $2.6 Million Public Offering GlobeNewswire
Jun-03	ReShape Lifesciences Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio GlobeNewswire
May-21	ReShape Lifesciences Reports First Quarter Ended March 31, 2025 Financial Results and Provides Corporate Update GlobeNewswire
May-07	ReShape Lifesciences Announces 1-for-25 Reverse Stock Split GlobeNewswire
May-02	ReShape Lifesciences Presents Pre-clinical Data on Its Proprietary Diabetes Neuromodulation Device at the 12th Annual Minnesota Neuromodulation Symposium GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)